Evozyne

Developer of proteins using protein engineering technology

placeChicago, Illinois, United States calendar_todayFounded 2020 groups73 employees language evozyne.com

Innovation

1 patent family — focus: Physics & computing; filing pace active. Cited 6 times.

YearFilings
20241
20251

Social engagement

Social engagement: 8.7K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Fidelity Investments, Orbimed.

Investor typeCountShare
Venture capital240%
Private equity120%
Other / undisclosed240%

Recent activity

15 Jul 2025
Recognition
Coming soon